Skip to main content

CLGN · CollPlant Biotechnologies Ltd · Webcasts, Transcripts & Audio

Track CLGN — free
$4.64 +0.68 (+17.17%) At close · Nov 12 Q3 2024 earnings call transcript
Market Cap
$14.27M
Shares
3.08M
Volume · Nov 12 439.3K Avg daily vol (49 sessions) 74.48K

CollPlant Biotechnologies Ltd Webcasts

Earnings calls, investor updates, investor days and conferences for CollPlant Biotechnologies Ltd (CLGN), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY24 · Q3
2024-09-30
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q3 2024 Earnings Call Transcript
Positive tone Regenerative breast implant preclinical study Business development and partnerships rhCollagen platform / technology
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-06-30
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q2 2024 Earnings Call Transcript
Confident tone AbbVie dermal filler partnership Regenerative breast implant program rhCollagen and bioink platform
Revenue
$249,000
▼ 97.6% YoY
Diluted EPS
$3.70
▼ 24.5% YoY
Gross margin
-115.3%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-03-31
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q1 2024 Earnings Call Transcript
Positive tone AbbVie Dermal Filler Partnership Regenerative Breast Implants FDA Regulatory Pathway
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-12-31
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q4 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-09-30
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q3 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-06-30
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q2 2023 Earnings Call Transcript
Revenue
$10.18M
▲ 15330.3% YoY
Diluted EPS
$4.90
Gross margin
94.0%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-03-31
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q1 2023 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-31
Date not confirmed
CollPlant Biotechnologies Ltd (CLGN) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–8 of 8 webcasts
Key facts CIK 1631487 CUSIP M2R51X124 13F (30d) 7 filings 7 filers Visit website Investor relations